Overexpression of AlB1 in nasopharyngeal carcinomas correlates closely with advanced tumor stage

American Journal of Clinical Pathology

Volumn 129, Issue 5, 2008, Pages 728-734

  Liu, Meng Zhong ^a   Xie, Dan ^a   Mai, Shi Juan ^a   Tong, Zhu Ting ^a   Shao, Jian Yong ^a   Fu, Yong Shui ^b   Xia, Wen Jie ^b   Kung, Hsian Fu ^a   Guan, Xin Yuan ^a,c   Zeng, Yi Xin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Guangzhou Blood Center   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

AlB1; Amplification; Immunohistochemistry; Nasopharyngeal carcinoma; Tissue microarray

Indexed keywords

KI 67 ANTIGEN; STEROID RECEPTOR COACTIVATOR 3; HISTONE ACETYLTRANSFERASE; NUCLEAR RECEPTOR COACTIVATOR 3; TRANSACTIVATOR PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CELL PROLIFERATION; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; NASOPHARYNX CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; BIOSYNTHESIS; CARCINOMA; METABOLISM; MIDDLE AGED; NASOPHARYNX TUMOR; PATHOLOGY;

ADOLESCENT; ADULT; AGED; CARCINOMA; FEMALE; HISTONE ACETYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; TISSUE ARRAY ANALYSIS; TRANS-ACTIVATORS;

EID: 44849122637     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/QMDTL82JKEX6E7H2     Document Type: Article

References (28)

1. Parkin DM, Whelan SL, Ferlay J, et al, eds. Cancer Incidence in Five Continents, Vol VIII. Lyon, France: IARC Press; 2003:218-219. IARC scientific publication 155.
2. Lin JC, Jan JS, Hsu CY, et al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol. 2003;21:631-637.
3. Chow E, Payne D, O'Sullivan B, et al. Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an Intergroup study: is combined modality treatment really necessary? Radiother Oncol. 2002;63:269-274.
4. Wong N, Hui AB, Fan B, et al. Molecular cytogenetic characterization of nasopharyngeal carcinoma cell lines and xenografts by comparative genomic hybridization and spectral karyotyping. Cancer Genet Cytogenet. 2003;140:124-132.
5. Or YY, Hui AB, Tam KY, et al. Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines. Int J Oncol. 2005;26:49-56.
6. Yan W, Song L, Wei W, et al. Chromosomal abnormalities associated with neck nodal metastasis in nasopharyngeal carcinoma. Tumour Biol. 2005;26:306-312.
7. Schwa M. Oncogene amplification in solid tumors. Semin Cancer Biol. 1999;9:319-325.
8. Anzick SL, Kononen J, Walker RL, et al. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 1997;277:965-968.
9. Liao L, Kuang SQ, Yuan Y, et al. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator AIB1/AIB1. J Steroid Biochem Mol Biol. 2002;83:3-14.
10. Gnanapragasam VJ, Leung HY, Pulimood AS, et al. Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer. Br J Cancer. 2001;85:1928-1936.
11. Tanner MM, Grenman S, Koul A, et al. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res. 2000;6:1833-1839.
12. Xu FP, Xie D, Wen JM, et al. SRC-3/AIB1 protein and gene amplification levels in human esophageal squamous cell carcinomas. Cancer Lett. 2007;245:69-74.
13. Sakakura C, Hagiwara A, Yasuoka R, et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer. 2000;89:217-223.
14. Xie D, Sham JS, Zeng WF, et al. Correlation of AIB1 overexpression with advanced clinical stage of human colorectal carcinoma. Hum Pathol. 2005;36:777-783.
15. Wang Y, Wu MC, Sham JS, et al. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma; a broad survey using high-throughput tissue microarray. Cancer. 2002;95:2346-2352.
16. Lung HL, Bangarusamy DK, Xie D, et al. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma. Oncogene. 2005;24:6525-6532.
17. Sobin LH, Wittekind C; for the International Union Against Cancer (UICC), eds. TNM Classification of Malignant Tumours. 6th ed. New York, NY: Wiley-Liss; 2002.
18. Xie D, Sham JS, Zeng WF, et al. Heterogeneous expression and association of beta-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray. Int J Cancer. 2003;107:896-902.
19. Bouras T, Southey MC, Venter DJ, et al. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res. 2001;61:903-907.
20. Henke RT, Haddad BR, Kim SE, et al. Overexpression of the nuclear receptor coactivator AIB1 (SRC-3) during progression of pancreatic adenocarcinoma. Clin Cancer Res. 2004;10:6134-6142.
21. Kuang SQ, Liao L, Zhang H, et al. AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in mice. Cancer Res. 2004;64:1875-1885.
22. Louie MC, Zou JX, Rabinovich A, et al. ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol Cell Biol. 2004;24:5157-5171.
23. Oh A, List HJ, Reiter R, et al. The nuclear receptor coactivator AIB1 mediates insulin-like growth factor I-induced phenotypic changes in human breast cancer cells. Cancer Res. 2004;64:299-308.
24. Stark GR, Debatisse M, Giulotto E, et al. Recent progress in understanding mechanisms of mammalian DNA amplification. Cell. 1989;57:901-908.
25. Wu RC, Qin J, Hashimoto Y, et al. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase. Mol Cell Biol. 2002;22:3549-3561.
26. Lauritsen KJ, List HJ, Reiter R, et al. A role for TGF-beta in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells. Oncogene. 2002;21:7147-7155.
27. Mani A, Oh AS, Bowden ET, et al. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Res. 2006;66:8680-8686.
28. Louie MC, Revenko AS, Zou JX, et al. Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity. Mol Cell Biol. 2006;26:3810-3823.